Freeha Rafiq

Freeha Rafiq is a seasoned communications professional with extensive experience in corporate communications, patient advocacy, and public relations within the pharmaceutical industry. Currently serving as Director of Corporate Communications at Amicus Therapeutics since November 2023, Freeha Rafiq's previous roles include Director of Franchise Communications for Europe and Canada at Takeda, Associate Director of Communications and Patient Advocacy at Takeda UK and Ireland, and various positions at Otsuka Pharmaceutical Companies, AbbVie, Novo Nordisk, and Amgen, demonstrating a strong background in R&D communications, event management, and stakeholder engagement. Earlier career experience includes roles in marketing communications at UCB Pharma, O2 UK, and Avery Dennison. Freeha Rafiq holds a BA (Hons) in Business and Marketing from Brunel University of London.